Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scintillation Counting | 59 | 2023 | 97 | 17.030 |
Why?
|
| Plastics | 42 | 2022 | 93 | 10.020 |
Why?
|
| Radiometry | 55 | 2023 | 980 | 7.050 |
Why?
|
| Proton Therapy | 29 | 2024 | 1577 | 4.890 |
Why?
|
| Brachytherapy | 21 | 2024 | 977 | 3.960 |
Why?
|
| Photons | 21 | 2022 | 507 | 3.180 |
Why?
|
| Gamma Rays | 9 | 2018 | 242 | 2.840 |
Why?
|
| Iridium Radioisotopes | 6 | 2019 | 56 | 2.500 |
Why?
|
| Monte Carlo Method | 26 | 2024 | 671 | 2.440 |
Why?
|
| Electrons | 10 | 2023 | 168 | 2.430 |
Why?
|
| Radiotherapy Dosage | 58 | 2024 | 3842 | 2.430 |
Why?
|
| Phantoms, Imaging | 29 | 2024 | 1271 | 2.350 |
Why?
|
| Protons | 7 | 2024 | 473 | 2.300 |
Why?
|
| Optical Fibers | 10 | 2020 | 37 | 2.120 |
Why?
|
| Radiation Dosage | 23 | 2019 | 1014 | 1.860 |
Why?
|
| Particle Accelerators | 14 | 2014 | 352 | 1.840 |
Why?
|
| Water | 16 | 2023 | 361 | 1.740 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 27 | 2024 | 2370 | 1.690 |
Why?
|
| Artifacts | 10 | 2020 | 532 | 1.450 |
Why?
|
| Radiation Dosimeters | 2 | 2020 | 8 | 1.450 |
Why?
|
| Respiration | 6 | 2016 | 447 | 1.390 |
Why?
|
| Equipment Design | 27 | 2015 | 1204 | 1.380 |
Why?
|
| Radiotherapy, Image-Guided | 4 | 2020 | 304 | 1.330 |
Why?
|
| Calibration | 15 | 2023 | 337 | 1.300 |
Why?
|
| Temperature | 8 | 2018 | 506 | 1.220 |
Why?
|
| Scattering, Radiation | 10 | 2018 | 316 | 1.220 |
Why?
|
| Linear Energy Transfer | 5 | 2020 | 98 | 1.190 |
Why?
|
| Intraoperative Care | 5 | 2006 | 259 | 1.160 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2022 | 1648 | 1.150 |
Why?
|
| Radiotherapy, High-Energy | 11 | 2010 | 295 | 1.130 |
Why?
|
| Radiotherapy, Conformal | 11 | 2022 | 902 | 1.120 |
Why?
|
| Equipment Failure Analysis | 20 | 2015 | 329 | 1.100 |
Why?
|
| Radiotherapy, Intensity-Modulated | 16 | 2024 | 2104 | 1.100 |
Why?
|
| Motion | 3 | 2016 | 193 | 1.050 |
Why?
|
| Models, Theoretical | 7 | 2016 | 785 | 1.040 |
Why?
|
| Algorithms | 14 | 2024 | 3890 | 0.970 |
Why?
|
| Radiotherapy | 11 | 2016 | 1824 | 0.960 |
Why?
|
| Fiber Optic Technology | 8 | 2013 | 142 | 0.940 |
Why?
|
| Gamma Cameras | 2 | 2013 | 40 | 0.840 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2018 | 925 | 0.840 |
Why?
|
| Light | 6 | 2014 | 245 | 0.820 |
Why?
|
| Cobalt Radioisotopes | 4 | 2015 | 42 | 0.790 |
Why?
|
| Radionuclide Imaging | 3 | 2020 | 660 | 0.790 |
Why?
|
| Luminescence | 2 | 2017 | 44 | 0.750 |
Why?
|
| Liver Neoplasms | 10 | 2019 | 4557 | 0.740 |
Why?
|
| Inorganic Chemicals | 1 | 2019 | 2 | 0.730 |
Why?
|
| Breath Holding | 2 | 2019 | 44 | 0.730 |
Why?
|
| Cone-Beam Computed Tomography | 3 | 2021 | 202 | 0.690 |
Why?
|
| Fiducial Markers | 1 | 2020 | 96 | 0.690 |
Why?
|
| Reproducibility of Results | 27 | 2015 | 6009 | 0.680 |
Why?
|
| Polystyrenes | 4 | 2016 | 32 | 0.680 |
Why?
|
| In Vivo Dosimetry | 3 | 2024 | 3 | 0.670 |
Why?
|
| Perioperative Nursing | 3 | 2003 | 6 | 0.650 |
Why?
|
| Photometry | 2 | 2015 | 23 | 0.640 |
Why?
|
| Abdomen | 1 | 2020 | 332 | 0.630 |
Why?
|
| Europium | 1 | 2017 | 7 | 0.610 |
Why?
|
| Optical Phenomena | 2 | 2013 | 26 | 0.590 |
Why?
|
| Lasers, Solid-State | 1 | 2016 | 16 | 0.580 |
Why?
|
| Rectum | 3 | 2024 | 467 | 0.540 |
Why?
|
| Semiconductors | 5 | 2014 | 22 | 0.540 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2016 | 51 | 0.540 |
Why?
|
| Fourier Analysis | 1 | 2015 | 94 | 0.530 |
Why?
|
| Sensitivity and Specificity | 22 | 2015 | 4971 | 0.510 |
Why?
|
| Four-Dimensional Computed Tomography | 2 | 2019 | 226 | 0.510 |
Why?
|
| Radiosurgery | 7 | 2023 | 1330 | 0.510 |
Why?
|
| Physical Phenomena | 1 | 2014 | 20 | 0.510 |
Why?
|
| Mobile Health Units | 2 | 2006 | 34 | 0.490 |
Why?
|
| Prostatic Neoplasms | 8 | 2022 | 5767 | 0.490 |
Why?
|
| Quality Assurance, Health Care | 6 | 2014 | 585 | 0.460 |
Why?
|
| Feasibility Studies | 8 | 2016 | 2292 | 0.450 |
Why?
|
| Radiotherapy, Computer-Assisted | 2 | 2011 | 126 | 0.450 |
Why?
|
| Humans | 92 | 2024 | 261506 | 0.440 |
Why?
|
| Carbon | 1 | 2013 | 149 | 0.440 |
Why?
|
| Movement | 4 | 2012 | 556 | 0.440 |
Why?
|
| Dose-Response Relationship, Radiation | 10 | 2019 | 726 | 0.440 |
Why?
|
| Skin | 1 | 2018 | 1259 | 0.420 |
Why?
|
| Rectal Neoplasms | 4 | 2024 | 1202 | 0.420 |
Why?
|
| Thermoluminescent Dosimetry | 2 | 2011 | 77 | 0.420 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2019 | 7551 | 0.420 |
Why?
|
| Computer Simulation | 9 | 2020 | 1529 | 0.410 |
Why?
|
| Computer-Aided Design | 5 | 2010 | 73 | 0.390 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2008 | 209 | 0.380 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 148 | 0.380 |
Why?
|
| Oxides | 2 | 2008 | 211 | 0.370 |
Why?
|
| Radiation Protection | 3 | 2012 | 205 | 0.370 |
Why?
|
| Defibrillators, Implantable | 1 | 2012 | 221 | 0.340 |
Why?
|
| Radiographic Image Enhancement | 3 | 2008 | 402 | 0.340 |
Why?
|
| Oxygen | 1 | 2013 | 754 | 0.340 |
Why?
|
| Gold | 2 | 2007 | 270 | 0.320 |
Why?
|
| Implants, Experimental | 1 | 2007 | 17 | 0.320 |
Why?
|
| Quality Control | 5 | 2014 | 457 | 0.310 |
Why?
|
| Whole-Body Irradiation | 1 | 2008 | 307 | 0.310 |
Why?
|
| Triiodobenzoic Acids | 1 | 2008 | 68 | 0.310 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 1162 | 0.300 |
Why?
|
| Chemoradiotherapy | 6 | 2016 | 1946 | 0.300 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 2006 | 262 | 0.290 |
Why?
|
| Biomimetics | 1 | 2006 | 33 | 0.290 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 133 | 0.280 |
Why?
|
| Models, Biological | 3 | 2009 | 3254 | 0.270 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2019 | 2027 | 0.270 |
Why?
|
| Time Factors | 12 | 2020 | 12926 | 0.260 |
Why?
|
| Intraoperative Period | 5 | 2007 | 246 | 0.260 |
Why?
|
| Neoplasms | 10 | 2018 | 15193 | 0.260 |
Why?
|
| Organs at Risk | 3 | 2024 | 514 | 0.260 |
Why?
|
| Biophysical Phenomena | 4 | 2010 | 112 | 0.260 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 295 | 0.250 |
Why?
|
| Uncertainty | 3 | 2019 | 320 | 0.240 |
Why?
|
| Contrast Media | 2 | 2008 | 1472 | 0.240 |
Why?
|
| Cobalt Isotopes | 1 | 2003 | 6 | 0.230 |
Why?
|
| Anus Neoplasms | 3 | 2014 | 411 | 0.230 |
Why?
|
| Radiation Oncology | 2 | 2020 | 529 | 0.230 |
Why?
|
| Sigmoid Neoplasms | 1 | 2003 | 18 | 0.230 |
Why?
|
| Transducers | 1 | 2003 | 59 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 6 | 2023 | 5061 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 7702 | 0.230 |
Why?
|
| Adenosarcoma | 1 | 2003 | 16 | 0.230 |
Why?
|
| Adenocarcinoma | 7 | 2023 | 7789 | 0.220 |
Why?
|
| Radiography | 3 | 2024 | 1904 | 0.210 |
Why?
|
| Spectrum Analysis | 2 | 2013 | 139 | 0.200 |
Why?
|
| Computer Systems | 3 | 2011 | 106 | 0.180 |
Why?
|
| Male | 28 | 2024 | 123000 | 0.180 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2019 | 117 | 0.170 |
Why?
|
| Digestive System Neoplasms | 1 | 2019 | 82 | 0.170 |
Why?
|
| Machine Learning | 1 | 2021 | 319 | 0.170 |
Why?
|
| X-Rays | 2 | 2016 | 146 | 0.170 |
Why?
|
| Models, Statistical | 4 | 2010 | 1171 | 0.160 |
Why?
|
| Radiometric Dating | 1 | 2018 | 5 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 3168 | 0.160 |
Why?
|
| Synchrotrons | 1 | 2017 | 35 | 0.150 |
Why?
|
| Catheters | 3 | 2024 | 126 | 0.150 |
Why?
|
| Retrospective Studies | 13 | 2024 | 37905 | 0.150 |
Why?
|
| Software | 4 | 2014 | 1321 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2022 | 10035 | 0.140 |
Why?
|
| Film Dosimetry | 3 | 2006 | 59 | 0.140 |
Why?
|
| Fecal Incontinence | 1 | 1997 | 85 | 0.140 |
Why?
|
| Technology Assessment, Biomedical | 2 | 2006 | 59 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 2403 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 187 | 0.130 |
Why?
|
| Radiation Injuries | 2 | 2012 | 1411 | 0.130 |
Why?
|
| Datasets as Topic | 1 | 2015 | 181 | 0.130 |
Why?
|
| Evaluation Studies as Topic | 3 | 2005 | 418 | 0.130 |
Why?
|
| Radiography, Abdominal | 1 | 2015 | 120 | 0.120 |
Why?
|
| Lymphopenia | 1 | 2016 | 199 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 676 | 0.120 |
Why?
|
| Lenses | 1 | 2013 | 14 | 0.120 |
Why?
|
| Sucrose | 1 | 2013 | 64 | 0.110 |
Why?
|
| Polymethyl Methacrylate | 1 | 2013 | 41 | 0.110 |
Why?
|
| Gases | 1 | 2012 | 36 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 462 | 0.110 |
Why?
|
| Solutions | 2 | 2009 | 104 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1724 | 0.110 |
Why?
|
| Dilatation | 1 | 2012 | 83 | 0.110 |
Why?
|
| Immobilization | 1 | 2012 | 93 | 0.100 |
Why?
|
| Prostate | 3 | 2022 | 1088 | 0.100 |
Why?
|
| Genitalia, Female | 1 | 2012 | 68 | 0.100 |
Why?
|
| Duodenum | 1 | 2012 | 149 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2014 | 5437 | 0.100 |
Why?
|
| Ohio | 2 | 2001 | 113 | 0.100 |
Why?
|
| Iridium | 1 | 2011 | 4 | 0.100 |
Why?
|
| Optics and Photonics | 2 | 2009 | 146 | 0.100 |
Why?
|
| Operating Rooms | 2 | 2003 | 122 | 0.100 |
Why?
|
| Gels | 1 | 2011 | 105 | 0.100 |
Why?
|
| Safety | 1 | 2013 | 465 | 0.100 |
Why?
|
| Catheterization | 1 | 2012 | 410 | 0.090 |
Why?
|
| Combined Modality Therapy | 5 | 2014 | 8865 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2012 | 213 | 0.090 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2005 | 2231 | 0.080 |
Why?
|
| Magnetics | 1 | 2009 | 107 | 0.080 |
Why?
|
| Aged | 16 | 2023 | 70117 | 0.080 |
Why?
|
| Silicon | 1 | 2008 | 48 | 0.080 |
Why?
|
| Filtration | 1 | 2008 | 92 | 0.080 |
Why?
|
| Female | 18 | 2024 | 141928 | 0.080 |
Why?
|
| Transistors, Electronic | 1 | 2007 | 7 | 0.080 |
Why?
|
| Liver | 2 | 2008 | 2961 | 0.080 |
Why?
|
| Biofeedback, Psychology | 1 | 2007 | 49 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2011 | 499 | 0.080 |
Why?
|
| Rotation | 1 | 2007 | 112 | 0.080 |
Why?
|
| Induction Chemotherapy | 3 | 2016 | 669 | 0.070 |
Why?
|
| Body Temperature | 1 | 2007 | 158 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 573 | 0.070 |
Why?
|
| Palliative Care | 2 | 2006 | 2037 | 0.070 |
Why?
|
| Radiology | 1 | 2012 | 434 | 0.070 |
Why?
|
| Placebos | 1 | 2007 | 437 | 0.070 |
Why?
|
| Body Burden | 1 | 2006 | 65 | 0.070 |
Why?
|
| Middle Aged | 15 | 2019 | 86204 | 0.070 |
Why?
|
| International Agencies | 1 | 2006 | 107 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2008 | 334 | 0.070 |
Why?
|
| Miniaturization | 1 | 2005 | 47 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 180 | 0.070 |
Why?
|
| Relative Biological Effectiveness | 1 | 2006 | 219 | 0.070 |
Why?
|
| Biophysics | 2 | 1996 | 111 | 0.070 |
Why?
|
| Radioimmunodetection | 2 | 2003 | 16 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2014 | 3578 | 0.060 |
Why?
|
| Telemetry | 1 | 2005 | 39 | 0.060 |
Why?
|
| Radio Waves | 1 | 2005 | 25 | 0.060 |
Why?
|
| Internationality | 1 | 2006 | 208 | 0.060 |
Why?
|
| Radiology, Interventional | 1 | 2006 | 138 | 0.060 |
Why?
|
| Models, Structural | 2 | 1994 | 103 | 0.060 |
Why?
|
| Ions | 1 | 2004 | 53 | 0.060 |
Why?
|
| Cesium Radioisotopes | 1 | 2004 | 39 | 0.060 |
Why?
|
| Technology, Radiologic | 2 | 1994 | 80 | 0.060 |
Why?
|
| Anisotropy | 1 | 2004 | 181 | 0.060 |
Why?
|
| Perioperative Care | 1 | 2007 | 451 | 0.060 |
Why?
|
| Surgical Equipment | 1 | 2003 | 17 | 0.060 |
Why?
|
| Radiopharmaceuticals | 2 | 2006 | 1301 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2019 | 32848 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 29902 | 0.060 |
Why?
|
| Bile Duct Neoplasms | 1 | 2008 | 493 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 15862 | 0.050 |
Why?
|
| Cholangiocarcinoma | 1 | 2008 | 493 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1945 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2007 | 795 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2009 | 2803 | 0.050 |
Why?
|
| Automation | 1 | 2022 | 151 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2023 | 129 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2022 | 233 | 0.050 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.050 |
Why?
|
| Indium Radioisotopes | 1 | 2001 | 65 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2011 | 1529 | 0.050 |
Why?
|
| Canada | 2 | 2012 | 429 | 0.050 |
Why?
|
| Program Development | 1 | 2001 | 261 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2022 | 285 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2006 | 1335 | 0.040 |
Why?
|
| Adult | 10 | 2016 | 77950 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 993 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2578 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 1021 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2011 | 2278 | 0.040 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 10001 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2022 | 13658 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 2588 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 718 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 4849 | 0.040 |
Why?
|
| Genital Neoplasms, Female | 1 | 2004 | 735 | 0.040 |
Why?
|
| Defecation | 1 | 1997 | 58 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 388 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6207 | 0.030 |
Why?
|
| Sarcoma | 1 | 2006 | 1725 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 4988 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2014 | 9180 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 14889 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 622 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 486 | 0.030 |
Why?
|
| Microtechnology | 1 | 2014 | 12 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 4975 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1997 | 297 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 1994 | 49 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1997 | 467 | 0.030 |
Why?
|
| Quebec | 1 | 2013 | 20 | 0.030 |
Why?
|
| Pressure | 1 | 1994 | 215 | 0.030 |
Why?
|
| Inventions | 1 | 2013 | 37 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 209 | 0.030 |
Why?
|
| Morbidity | 1 | 2014 | 397 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2012 | 44 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2012 | 170 | 0.030 |
Why?
|
| Nuclear Medicine | 2 | 2004 | 46 | 0.030 |
Why?
|
| Dehydration | 1 | 2011 | 87 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 2316 | 0.020 |
Why?
|
| Color | 1 | 2011 | 66 | 0.020 |
Why?
|
| Medical Errors | 1 | 2013 | 219 | 0.020 |
Why?
|
| Anorexia | 1 | 2011 | 143 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 690 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 4844 | 0.020 |
Why?
|
| Capecitabine | 1 | 2011 | 388 | 0.020 |
Why?
|
| Probability | 1 | 2012 | 866 | 0.020 |
Why?
|
| Vagina | 1 | 2012 | 317 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1987 | 0.020 |
Why?
|
| Nausea | 1 | 2011 | 525 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 3441 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 702 | 0.020 |
Why?
|
| Protective Devices | 1 | 2008 | 21 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2011 | 451 | 0.020 |
Why?
|
| Exhalation | 1 | 2008 | 60 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 2307 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2009 | 152 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 4367 | 0.020 |
Why?
|
| Taxoids | 1 | 2011 | 967 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 187 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.020 |
Why?
|
| Muscles | 1 | 2008 | 416 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2011 | 1944 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 1353 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12221 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 1223 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2004 | 74 | 0.010 |
Why?
|
| Palladium | 1 | 2003 | 56 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2008 | 769 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2012 | 12873 | 0.010 |
Why?
|
| Radioisotopes | 1 | 2003 | 177 | 0.010 |
Why?
|
| Kidney | 1 | 2011 | 2146 | 0.010 |
Why?
|
| Child | 1 | 2024 | 29154 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2003 | 371 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2001 | 281 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 6869 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 2173 | 0.010 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2003 | 690 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 4298 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3890 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1994 | 3976 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 3443 | 0.010 |
Why?
|
| Radiation | 1 | 1991 | 20 | 0.010 |
Why?
|
| United States | 1 | 2004 | 15433 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 14289 | 0.000 |
Why?
|